Infection Prevention in the Deployed Environment

Heather C. Yun, Clinton K. Murray

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Up to 50% of combat injured patients from recent conflicts have suffered infectious complications, predominantly with multidrug-resistant (MDR) bacteria acquired nosocomially in the chain of tactical combat casualty care. These bacteria have ranged from MDR Acinetobacter baumannii-calcoaceticus associated with Operation Iraqi Freedom (OIF), to extended spectrum beta-lactamase producing Enterobacteriaceae from operations in Afghanistan. Experience from interventions at Level III facilities demonstrate that basic infection control (IC) procedures, such as improvements in hand hygiene, use of ventilator associated pneumonia bundles, and antimicrobial stewardship, can improve outcomes even in austere environments. While some systematic interventions have been implemented to mitigate this risk, including development of the Deployed Infection Control Course, the Multidrug-Resistance Surveillance Network, and the Trauma Infectious Disease Outcomes Study, ongoing vulnerabilities remain. Deployed microbiology capabilities should be strengthened, theater-level IC standard operating procedures should be implemented, and a joint, theater-level expert IC consultant should be appointed to be responsible for directing IC activities from Levels I to IV.

Original languageEnglish
Pages (from-to)114-118
Number of pages5
JournalU.S. Army Medical Department journal
Issue number2-16
StatePublished - 1 Apr 2016


Dive into the research topics of 'Infection Prevention in the Deployed Environment'. Together they form a unique fingerprint.

Cite this